Lymphoma Update: CAR T Therapies and Checkpoint Inhibitors

Wednesday, May 16, 2018

Video05:17

Lymphoma experts Anas Younes, MD and Andrew Zelenetz, MD, PhD discuss the fast evolving research on CAR T cells and checkpoint inhibitors that is yielding the novel treatment options improving both outcomes and quality of life for people with lymphoma.

People of MSK

People of MSK

{{{ _highlightResult.full_name.value }}}{{{ _highlightResult.degree.value }}}

{{{ _snippetResult.title.value }}}

{{{ _snippetResult.lay_title.value }}}

{{{ _highlightResult.full_name.value }}}{{{ _highlightResult.degree.value }}}

{{{ _highlightResult.full_name.value }}}{{{ _highlightResult.degree.value }}}

{{ formattedDate }} - {{{ _snippetResult.title.value }}}

{{{ _snippetResult.title.value }}}

Suggested Results (more)

Diseases (more)

Doctors (more)

Locations (more)

News and Stories (more)

Clinical Trials (more)

Research Labs (more)

Other Results (more)